Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Laslop

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Annals of the New York Academy of Sciences|November 20, 2002
Neuropeptides and chromogranins: session overviewAndrea Laslop, Sushil K Mahata
Clinical Pharmacology and Therapeutics|November 10, 2022
Assessing Medicines for Use in the Geriatric PopulationFrancesca Cerreta, Katarina Vučić, Andrea Laslop
Annals of the New York Academy of Sciences|November 20, 2002
Proteolytic processing of chromogranins is modified in brains of transgenic miceAndrea Laslop, Alexandra Becker, Iris Lindberg, et al.
Regulatory Peptides|March 1, 2003
Proteolytic processing of chromogranin A by the prohormone convertase PC2Alfred Doblinger, Alexandra Becker, Nabil G Seidah, et al.
Journal of Cell Science|January 22, 2004
Dense-core granules: a specific hallmark of the neuronal/neurosecretory cell phenotypeMaria Luisa Malosio, Tiziana Giordano, Andrea Laslop, et al.
Scientia Pharmaceutica|April 9, 2015
Reflections on Decisions Made on the Well-Established Use of Medicinal Products by EU Regulators and the ECJJohn Joseph Borg, Andrea Laslop, Luca Pani, et al.
Annals of the New York Academy of Sciences|November 20, 2002
Neuroendocrine secretory protein 55: a novel marker for the constitutive secretory pathwayReiner Fischer-Colbrie, Susanne Eder, Paola Lovisetti-Scamihorn, et al.
Regulatory Peptides|January 12, 2002
Lack of a distinctive behavioural effect of chromogranin-derived peptides in rodentsGudrun Wakonigg, Gerald Zernig, Iris Berger, et al.
Neuro-Signals|January 4, 2005
Secretion and molecular forms of NESP55, a novel genomically imprinted neuroendocrine-specific protein from AtT-20 cellsSusanne Eder, Johannes Leierer, Lars Klimaschewski, et al.
Clinical Pharmacology and Therapeutics|September 2, 2021
Identifiability of Biologicals: An Analysis Using EudraVigilance, the European Union's Database of Reports of Suspected Adverse Drug ReactionsLuis Correia Pinheiro, Thijs J Giezen, Elena Wolff-Holz, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Annals of the New York Academy of Sciences|November 20, 2002
Neuropeptides and chromogranins: session overviewAndrea Laslop, Sushil K Mahata
Clinical Pharmacology and Therapeutics|November 10, 2022
Assessing Medicines for Use in the Geriatric PopulationFrancesca Cerreta, Katarina Vučić, Andrea Laslop
Annals of the New York Academy of Sciences|November 20, 2002
Proteolytic processing of chromogranins is modified in brains of transgenic miceAndrea Laslop, Alexandra Becker, Iris Lindberg, et al.
Regulatory Peptides|March 1, 2003
Proteolytic processing of chromogranin A by the prohormone convertase PC2Alfred Doblinger, Alexandra Becker, Nabil G Seidah, et al.
Journal of Cell Science|January 22, 2004
Dense-core granules: a specific hallmark of the neuronal/neurosecretory cell phenotypeMaria Luisa Malosio, Tiziana Giordano, Andrea Laslop, et al.
Scientia Pharmaceutica|April 9, 2015
Reflections on Decisions Made on the Well-Established Use of Medicinal Products by EU Regulators and the ECJJohn Joseph Borg, Andrea Laslop, Luca Pani, et al.
Annals of the New York Academy of Sciences|November 20, 2002
Neuroendocrine secretory protein 55: a novel marker for the constitutive secretory pathwayReiner Fischer-Colbrie, Susanne Eder, Paola Lovisetti-Scamihorn, et al.
Regulatory Peptides|January 12, 2002
Lack of a distinctive behavioural effect of chromogranin-derived peptides in rodentsGudrun Wakonigg, Gerald Zernig, Iris Berger, et al.
Neuro-Signals|January 4, 2005
Secretion and molecular forms of NESP55, a novel genomically imprinted neuroendocrine-specific protein from AtT-20 cellsSusanne Eder, Johannes Leierer, Lars Klimaschewski, et al.
Clinical Pharmacology and Therapeutics|September 2, 2021
Identifiability of Biologicals: An Analysis Using EudraVigilance, the European Union's Database of Reports of Suspected Adverse Drug ReactionsLuis Correia Pinheiro, Thijs J Giezen, Elena Wolff-Holz, et al.
Pageof 5